interferoninduc
transmembran
ifitm
protein
famili
viral
restrict
factor
play
critic
role
interferonmedi
control
influenza
viru
iav
protein
inhibit
iav
replic
infect
hemagglutinin
ha
pseudotyp
retrovirus
indic
target
iav
entri
process
ifitm
protein
also
restrict
earli
step
lifecycl
sever
flavivirus
includ
dengu
west
nile
virus
contrast
inhibit
replic
murin
leukemia
viru
mlv
entri
process
amphotrop
mlv
machupo
viru
macv
lassa
viru
lasv
lymphocyt
choriomening
viru
lcmv
although
ifitm
protein
induc
type
ii
interferon
cell
cell
line
express
basal
level
one
protein
express
wide
rang
tissu
wherea
express
appear
limit
bone
mice
ortholog
well
two
addit
ifitm
gene
pseudogen
speci
two
ifitm
protein
identifi
chicken
ortholog
human
ifitm
protein
small
amino
acid
two
transmembran
domain
separ
highli
conserv
cytoplasm
domain
amino
carboxi
domain
lumin
envelop
virus
usual
express
surfac
protein
mediat
attach
virion
cellular
receptor
follow
receptor
engag
entri
protein
undergo
conform
chang
ultim
promot
mix
viral
cellular
membran
lipid
format
fusion
pore
transfer
viral
genom
cell
cytoplasm
conform
chang
entri
protein
exampl
iav
ha
flaviviru
e
protein
induc
low
ph
fusion
mediat
protein
requir
access
acid
cellular
compart
late
endosom
lysosom
contrast
entri
protein
envelop
protein
mlv
requir
access
acid
compart
virus
presum
fuse
plasma
membran
earli
endocyt
vesicl
final
entri
protein
sever
acut
respiratori
syndrom
coronaviru
sarscov
spike
protein
filoviru
glycoprotein
indirectli
requir
low
ph
activ
targetcel
proteas
necessari
viral
entri
proteolyt
cleavag
entri
protein
lysosom
cathepsin
l
sarscov
cathepsin
b
l
ebola
viru
ebov
promot
final
step
viral
fusion
case
sarscov
requir
cathepsin
l
circumv
treatment
receptorbound
virion
trypsin
relat
proteas
observ
use
suggest
altern
pathway
sarscov
infect
depend
whether
cathepsin
l
extracellular
proteas
activ
receptorassoci
protein
demonstr
like
iav
entri
process
marburg
viru
marv
ebov
sarscov
specif
restrict
ifitm
protein
observ
variou
human
mous
chicken
ifitm
ortholog
differenti
restrict
iav
filovirus
show
restrict
sarscov
circumv
trypsin
treatment
cellassoci
virion
data
identifi
variat
properti
individu
ifitm
protein
local
restrict
activ
late
stage
endocyt
pathway
suggest
protein
restrict
broad
rang
envelop
virus
modul
cellular
tropism
independ
viral
receptor
express
ifitm
protein
restrict
iav
hamedi
entri
earli
stage
replic
sever
flavivirus
entri
process
virus
ph
depend
sought
determin
addit
virus
requir
access
late
endocyt
lysosom
compart
similarli
restrict
protein
entri
process
marv
ebov
requir
activ
one
cathepsin
whose
activ
local
lysosom
ebov
marv
requir
cathepsin
l
activ
infect
cell
wherea
ebov
also
requir
cathepsin
b
activ
accordingli
incub
mlvbase
pseudovirus
bear
entri
protein
marv
ebov
iav
mlv
macv
lung
epitheli
cell
transduc
express
human
vector
alon
previous
report
infect
mediat
entri
protein
mlv
macv
unaffect
presenc
ifitm
protein
fig
despit
effici
express
fig
contrast
report
iav
hamedi
entri
markedli
inhibit
protein
similarli
observ
entri
mediat
marv
ebov
protein
inhibit
fig
compar
result
obtain
vero
cell
african
green
monkey
kidney
epitheli
cell
line
standard
cell
line
laboratori
propag
virus
fig
human
umbil
vein
endotheli
cell
huvec
primari
cell
target
filoviru
infect
fig
f
repeatedli
observ
ifitmmedi
restrict
less
effici
human
embryon
kidney
cell
consist
observ
iav
ha
filoviru
entri
partial
suppress
cell
wherea
control
pseudovirus
remain
unaffect
fig
h
data
indic
restrict
marv
ebov
entri
identifi
celltyp
differ
effici
restrict
specul
differ
aris
express
differ
necessari
restrict
cofactor
protein
interfer
ifitm
protein
activ
express
ifitm
protein
potent
induc
type
type
ii
interferon
fig
determin
whether
entri
process
marv
ebov
similarli
regul
type
ifn
incub
hela
cell
infect
cell
pseudovirus
bear
marv
ebov
iav
macv
mlv
entri
protein
fig
previous
report
treatment
upregul
ifitm
protein
fig
consist
higher
express
ifitm
protein
entri
mediat
marv
ebov
iav
ha
markedli
inhibit
fig
contrast
infect
mlv
macv
pseudovirus
modestli
suppress
effect
possibl
due
postentri
inhibit
gfp
express
treat
cell
conclud
entri
process
marv
ebov
iav
inhibit
type
ifn
determin
whether
ifitm
protein
restrict
infecti
filovirus
vero
cell
transduc
express
vector
alon
incub
infecti
marv
ebov
moi
observ
pseudovirus
replic
infecti
filovirus
restrict
express
ifitm
protein
fig
consist
similar
result
obtain
cell
fig
thu
express
suppress
replic
infecti
marv
ebov
collect
fig
data
suggest
suppress
filoviru
replic
ifitm
protein
type
interferon
due
part
inhibit
entri
case
marv
ebov
sarscov
requir
cathepsin
l
activ
enter
cell
therefor
investig
whether
ifitm
protein
could
restrict
sarscov
proteinmedi
entri
first
introduc
sarscov
receptor
angiotensinconvert
enzym
cell
transduc
express
vector
alon
entri
mediat
sarscov
protein
like
iav
hamedi
entri
restrict
ifitm
protein
wherea
mlv
macv
pseudovirus
unaffect
fig
ifitm
express
substanti
interfer
cellsurfac
express
indic
suppress
due
receptor
downregul
fig
c
similar
result
obtain
vero
cell
fig
e
f
consist
sarscov
pseudovirus
infecti
sarscov
replic
control
vero
cell
markedli
effici
cell
express
fig
h
conclud
like
ebov
marv
sarscov
entri
restrict
ifitm
throughout
studi
observ
modest
trend
cell
overexpress
ifitm
protein
effici
restrict
iav
wherea
similar
pattern
observ
marv
ebov
sarscov
explor
differ
hela
cell
transduc
express
shrna
target
shrna
target
express
cell
maintain
presenc
absenc
incub
marv
ebov
iav
mlv
macv
pseudovirus
fig
b
expect
effici
inhibit
entri
mediat
marv
ebov
iav
ha
protein
deplet
fulli
restor
iav
hamedi
infect
effect
modestli
enhanc
suppress
express
contrast
entri
mediat
marv
ebov
restor
cell
express
shrna
target
express
howev
deplet
filoviru
entri
partial
restor
result
suggest
iav
entri
sensit
restrict
wherea
play
import
role
suppress
filoviru
entri
process
examin
differ
profil
ifitm
restrict
cell
endogen
express
ifitm
protein
hela
cell
express
detect
basal
level
fig
shrna
target
markedli
enhanc
entri
mediat
four
iav
ha
protein
assay
substanti
increas
infect
marv
ebov
control
pseudovirus
fig
fig
similarli
ifitmtarget
shrna
affect
entri
sarscov
pseudoviru
hela
cell
wherea
iav
infect
markedli
enhanc
shrna
fig
express
compar
control
cell
fig
explor
role
endogen
use
human
myelogen
leukemia
cell
express
rel
high
level
ifitm
protein
fig
deplet
markedli
enhanc
entri
marv
lesser
extent
iav
pseudovirus
fig
similarli
shrna
target
alter
express
enhanc
sarscov
proteinmedi
entri
fig
thu
cell
express
differ
basal
level
ifitm
protein
level
differenti
alter
suscept
iav
cathepsindepend
virus
explor
extent
ifitm
protein
differenti
restrict
iav
filovirus
cell
transduc
express
known
human
fig
b
mous
fig
chicken
fig
f
ifitm
ortholog
cell
incub
pseudovirus
bear
marv
ebov
iav
mlv
macv
entri
protein
nearli
everi
ifitm
ortholog
restrict
marv
ebov
entri
despit
variat
express
ortholog
note
human
express
undetect
western
blot
observ
immunofluoresc
stain
fig
contrast
mous
chicken
mous
effici
restrict
iav
hamedi
entri
align
ifitm
ortholog
shown
fig
unlik
modest
differ
human
differ
suffici
observ
overexpress
assay
conclud
ifitm
gene
overlap
distinct
effect
entri
iav
filovirus
previou
studi
shown
cathepsin
l
depend
sarscov
bypass
addit
exogen
trypsin
virion
pseudovirion
like
induc
sproteinmedi
fusion
near
plasma
membran
contrast
cathepsin
lmediat
fusion
exogen
trypsin
promot
fusion
near
plasma
membran
local
ifitmmedi
restrict
investig
effect
trypsin
treatment
sarscov
entri
ifitmexpress
cell
vero
cell
transduc
express
vector
alon
incub
sarscov
macv
pseudovirus
expect
ifitm
express
restrict
sarscov
proteinmedi
entri
macv
gpcmediat
entri
contrast
sarscov
pseudovirion
bound
cell
incub
trypsin
short
time
entri
iftimexpress
cell
larg
restor
fig
b
c
data
suggest
ifitm
protein
restrict
cathepsindepend
entri
sarscov
lysosom
restrict
trypsininduc
fusion
near
plasma
membran
observ
ifitmexpress
cell
decreas
cellular
cathepsin
activ
could
readili
account
differ
fig
e
data
show
ifitmmedi
restrict
consequ
decreas
activ
lysosom
cathepsin
suggest
lysosom
ph
activ
cathepsin
b
l
similarli
unaffect
ifitm
protein
express
abil
circumv
ifitmmedi
restrict
bypass
requir
lysosom
cathespin
rais
possibl
ifitm
protein
interfer
access
virion
acid
cellular
compart
use
confoc
microscopi
monitor
infecti
iav
virion
minut
associ
virion
plasma
membran
vero
cell
transduc
express
vector
alon
fig
case
label
virion
readili
coloc
cellular
compart
label
lysotrack
fluoresc
indic
acid
compart
contrast
pretreat
cell
bacteri
neuraminidas
remov
iav
receptor
sialic
acid
cell
surfac
fig
bafilomycin
fig
prevent
acidif
late
endosom
lysosom
abolish
coloc
virion
acid
compart
data
suggest
ifitm
protein
interfer
access
virion
low
ph
compart
necessari
fusion
ifitmrestrict
virus
ifitm
protein
play
critic
role
intrins
interferonmedi
control
iav
replic
human
murin
cell
line
contrast
retrovir
restrict
factor
exampl
limit
replic
step
mediat
viral
entri
protein
like
fusion
viral
cellular
membran
although
initi
identifi
sirna
screen
factor
modul
iav
replic
also
inhibit
earli
step
lifecycl
sever
flavivirus
includ
dengu
west
nile
virus
entri
process
iav
flavivirus
requir
low
ph
intracellular
compart
promot
conform
chang
entri
protein
ha
e
protein
respect
investig
three
virus
two
filovirus
sarscov
similarli
requir
access
acid
compart
enter
cell
howev
unlik
iav
flavivirus
activ
viral
entri
protein
virus
directli
mediat
acid
ph
rather
acid
ph
necessari
activ
lysosom
proteas
turn
cleav
activ
entri
protein
marv
ebov
sarscov
entri
protein
requir
cathepsin
l
activ
mediat
fusion
addit
ebov
requir
cathepsin
b
activ
observ
like
iav
flavivirus
entri
process
three
cathepsindepend
virus
restrict
rang
human
ifitm
protein
mous
chicken
ortholog
yet
clear
ifitm
protein
restrict
virus
studi
consider
narrow
rang
possibl
mechan
first
number
divers
restrict
virus
tend
exclud
mechan
might
uniqu
individu
virus
previous
show
ifitm
protein
decreas
cellsurfac
express
sialic
acid
primari
attach
moieti
iav
similarli
ifitm
protein
significantli
alter
express
sarscov
receptor
plausibl
physic
interact
entri
protein
restrict
virus
ifitm
molecul
given
variat
among
entri
protein
eas
mechan
might
evad
howev
ifitmrestrict
virus
describ
date
requir
access
late
endosom
lysosom
compart
observ
rais
possibl
ifitm
protein
interfer
endosom
traffick
altern
make
compart
unsuit
fusion
restrict
virus
data
provid
clear
support
mechan
oper
later
stage
endocyt
pathway
specif
circumv
restrict
complement
cathepsin
l
requir
sarscov
exogen
trypsin
therebi
promot
fusion
near
plasma
membran
moreov
observ
ifitminduc
differ
effici
virion
access
acid
compart
cell
therefor
virus
restrict
restrict
late
endosom
lysosom
compart
howev
observ
loss
cathepsin
activ
ifitmexpress
cell
suggest
activ
acidif
requir
grossli
impair
ifitm
protein
cours
possibl
observ
reflect
underli
limit
abil
detect
relev
differ
particular
abil
detect
iav
acid
compart
ifitm
express
cell
exclud
possibl
compart
distinct
product
infect
occur
nonetheless
data
suggest
ifitm
protein
inhibit
viral
entri
mediat
chang
properti
late
endosom
lysosom
two
addit
observ
consist
hypothesi
first
cell
line
enlarg
vesicl
could
observ
ifitmexpress
cell
although
scale
enlarg
correl
effici
viral
restrict
second
particular
coloc
extens
marker
late
endosom
lysosom
poorli
marker
earli
endosom
fig
abil
bypass
ifitm
restrict
may
also
shed
light
cours
sarscov
infect
vivo
particular
follow
induct
interferon
respons
replic
viru
like
local
tissu
exampl
gastrointestin
respiratori
tract
trypsinlik
proteas
abund
also
observ
differ
ifitm
protein
restrict
iav
filovirus
differ
effici
gener
murin
ortholog
effici
restrict
iav
cathepsindepend
virus
indic
mark
increas
iav
entri
sarscov
ebov
marv
endogen
deplet
hela
cell
contrast
endogen
deplet
cell
effici
entri
observ
ifitmrestrict
virus
also
murin
chicken
effici
restrict
entri
mediat
filoviru
protein
littl
effect
iav
hamedi
entri
thu
pattern
basal
interferoninduc
express
ifitm
protein
like
independ
determin
viral
tropism
pathogenesi
vivo
human
embryon
kidney
human
cervic
carcinoma
hela
african
green
monkey
epitheli
vero
vero
cell
maintain
dulbecco
minim
essenti
medium
dmem
invitrogen
human
lung
epitheli
human
myelogen
leukemia
cell
grown
roswel
park
memori
institut
rpmi
medium
invitrogen
iscov
modifi
dulbecco
medium
imdm
invitrogen
respect
media
supplement
fetal
bovin
serum
fb
invitrogen
uml
penicillin
streptomycin
invitrogen
cell
transduc
vector
alon
stabli
express
ifitm
protein
select
puromycin
invitrogen
vero
vero
cell
transduc
vector
alon
stabli
express
ifitm
protein
maintain
growth
medium
supplement
puromycin
hela
cell
stabli
express
control
shrna
shrna
target
mrna
also
select
puromycin
human
umbil
vein
endotheli
cell
huvec
lonza
maintain
endotheli
cell
growth
supplement
bulletkit
lonza
dna
segment
encod
cmyc
tag
sequenc
agei
restrict
enzym
site
introduc
pqcxip
vector
clontech
plasmid
encod
variou
cmyctag
ifitm
protein
construct
polymeras
chain
reaction
pcr
amplif
code
region
human
mous
gene
use
plasmid
carri
respect
cdna
open
biosystem
templat
pcr
product
digest
ligat
ageibamhi
restrict
site
pqcxip
vector
codonoptim
chicken
human
mous
chicken
gene
synthes
genescript
also
clone
pqcxip
vector
pr
vectorbas
control
shrna
shrna
construct
target
human
mrna
purchas
origen
sequenc
control
target
code
region
mrna
follow
tgcacaaggaggaacatgaggtggctgtg
ccgcagcgagacctccgtgcctgaccatg
tgaatcacactgtccaaaccttcttctct
control
gcactaccagagctaactcagatagtact
plasmid
procedur
use
gener
pseudotyp
mlvgfp
previous
describ
variou
viral
entri
protein
use
entri
protein
includ
influenza
viru
ha
protein
pr
ud
thai
fpv
glycoprotein
marburg
viru
musok
marv
ebola
viru
mayinga
ebov
glycoprotein
gpc
machupo
viru
carvallo
macv
protein
sever
acut
respiratori
syndrom
coronaviru
sarscov
glycoprotein
gp
amphotroph
mlv
produc
transduc
virus
cell
plate
confluenc
cultur
flask
transfect
use
calcium
phosphat
method
plasmid
encod
macv
gpc
plasmid
dna
encod
mlv
gag
pol
pqcxipbas
plasmid
encod
variou
human
mous
chicken
ifitm
protein
prsbase
plasmid
encod
shrna
target
human
mrna
hour
transfect
cultur
supernat
harvest
filter
syring
filter
nalgen
cell
transduc
incub
transduc
virus
mix
polybren
santa
cruz
biotechnolog
centrifug
minut
transduc
cell
maintain
growth
medium
employ
stabl
cell
line
select
infect
hour
later
procedur
mlvgfp
pseudoviru
infect
similar
transduct
except
spin
inocul
use
polybren
includ
hour
infect
infect
cell
fix
formaldehyd
polysci
analyz
flow
cytometri
test
effect
type
interferon
ifn
entri
mlvgfp
pseudotyp
variou
viral
entri
protein
hela
cell
treat
uml
uml
human
antigenix
america
hour
pseudoviru
infect
trypsinbypass
experi
perform
similarli
except
follow
spin
inocul
cell
incub
trypsin
pb
alon
minut
propag
marv
variant
ebov
kikwit
variant
ebovgfp
mayinga
variant
describ
filoviru
infect
vero
cell
transduc
express
ifitm
protein
vector
alon
incub
marv
ebov
multipl
infect
moi
inocula
remov
h
later
cell
wash
time
phosphat
buffer
salin
pb
cultur
supernat
harvest
trizol
invitrogen
hour
infect
virion
yield
determin
quantit
revers
transcriptasepcr
qrtpcr
brief
total
rna
cultur
supernat
untreat
cell
mock
cell
infect
marv
ebov
prepar
use
magmax
rna
extract
kit
ambion
qrtpcr
assay
perform
abi
prism
sequenc
detect
system
rna
ultrasensetm
onestep
kit
invitrogen
taqman
probe
appli
biosystem
accord
manufactur
instruct
final
concentr
use
reaction
mix
contain
rna
primer
probe
reaction
mix
rox
enzym
mix
reaction
run
follow
revers
transcript
minut
initi
denatur
minut
amplif
cycl
second
second
serial
dilut
assay
copi
viru
use
standard
imag
marv
infect
cell
cell
fix
buffer
formalin
val
tech
diagnost
h
stain
highcont
quantit
imagebas
analysi
murin
monoclon
antibodi
marv
follow
alexa
goat
antimous
igg
invitrogen
infect
cell
stain
hoechst
hc
cellmask
red
invitrogen
imag
acquir
analyz
opera
confoc
reader
model
excit
high
sensit
qeh
perkin
elmer
two
exposur
use
air
object
propag
sarscov
describ
vero
cell
sort
express
moder
level
transduc
express
ifitm
protein
vector
alon
incub
sarscov
urbani
strain
multipl
infect
moi
hour
hour
infect
viral
titer
determin
plaqu
assay
cell
surfac
express
measur
label
cell
pierc
conjug
protein
receptorbind
domain
rbd
sarscov
one
hour
cell
wash
time
pb
fix
formaldehyd
analyz
flow
cytometri
imag
pseudoviru
infect
cell
cell
infect
variou
mlvgfp
pseudotyp
fix
formaldehyd
minut
permeabl
triton
sigma
minut
counterstain
ngml
dapi
sigma
minut
imag
taken
use
olympu
fluoresc
microscop
dp
control
softwar
object
express
human
cmyctag
ifitm
protein
cell
assay
use
similar
procedur
cell
transduc
express
human
ifitm
protein
vector
alon
fix
permeabl
label
fluorescein
isothiocyan
fitc
conjug
murin
anticmyc
igg
abcam
one
hour
counterstain
dapi
cell
imag
use
method
subcellular
local
human
measur
confoc
microscopi
cell
wash
twice
pb
fix
acetonemethanol
minut
fix
cell
wash
pb
twice
block
goat
serum
pb
label
variou
primari
antibodi
hour
primari
antibodi
use
studi
includ
murin
antilysosomalassoci
membran
protein
dilut
santa
cruz
biotech
murin
dilut
santa
cruz
biotech
murin
dilut
invitrogen
rabbit
antiearli
endosom
antigen
dilut
sigma
polyclon
antibodi
murin
anticmyc
antibodi
dilut
dilut
santa
cruz
biotech
primari
antibodi
stain
cell
label
goat
alexa
conjug
secondari
antibodi
dilut
invitrogen
hour
analyz
confoc
microscopi
use
leica
laser
confoc
imag
system
object
cathepsin
l
activ
assay
use
cathepsin
l
activ
kit
follow
protocol
provid
manufactur
emd
cathepsin
l
activ
vero
cell
transduc
express
ifitm
protein
vector
alon
assay
cathepsin
b
inhibitor
ad
test
sampl
elimin
interfer
cathepsin
b
evalu
cathepsin
b
l
activ
live
cell
magic
red
conjug
zleucinearginin
mr
rr
bind
activ
cathepsin
b
mr
conjug
zphenylalaninearginin
mr
fr
bind
activ
cathepsin
l
use
immunochemistri
technolog
vero
cell
transduc
express
ifitm
protein
empti
vector
incub
either
mr
rr
mr
fr
one
hour
later
cell
harvest
fix
formaldehyd
analyz
flow
cytometri
cell
lyse
either
triton
sigma
thermo
scientif
protein
sampl
prepar
reduc
buffer
boil
minut
analyz
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
sdspage
transfer
polyvinyliden
difluorid
membran
invitrogen
express
variou
cmyctag
ifitm
protein
detect
murin
monoclon
anticmyc
antibodi
santa
cruz
biotechnolog
endogen
ifitm
protein
express
probe
polyclon
rabbit
santa
cruz
biotechnolog
rabbit
dilut
antibodi
proteintech
group
cross
react
protein
recogn
murin
monoclon
antibodi
sigma
use
load
control
influenza
viru
purchas
american
type
cultur
collect
atcc
propag
madindarbi
canin
kidney
mdck
cell
describ
label
influenza
virion
virion
incub
alexa
pierc
conjug
monoclon
murin
antina
igg
hour
antibodi
gener
provid
dr
w
gerhard
wistar
institut
us
virion
use
infect
assay
directli
label
monitor
virion
traffick
vero
cell
transduc
express
ifitm
protein
vector
alon
incub
label
influenza
virion
moi
centrifug
minut
cell
wash
three
time
pb
maintain
medium
contain
nm
lysotrack
red
invitrogen
minut
later
cell
fix
formaldehyd
imag
leica
dmrbe
microscop
leica
laser
confoc
imag
system
object
control
cell
pretreat
uml
neuraminidas
clostridium
perfringen
sigma
hour
nm
bafilomycin
baf
sigma
hour
influenza
viru
infect
